NGFR and Alzheimer disease: Given the results discussed so far regarding the involvement of NGFR/p75NTR in the neuropathology of AD, since the mid-2000s, several research groups have tested in vivo and in vitro the effect of several molecules capable of blocking or altering the expression of these receptor for the treatment of this currently incurable disease [90].